BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:Europe/Amsterdam
X-WR-TIMEZONE:Europe/Amsterdam
BEGIN:VEVENT
UID:4505@worldglaucomaweek.org
DTSTART;TZID=Australia/Sydney:20220307T190000
DTEND;TZID=Australia/Sydney:20220307T200000
DTSTAMP:20220303T001005Z
URL:https://www.worldglaucomaweek.org/activity/earlier-surgical-interventi
 on-why-this-might-be-the-best-option-for-you/
SUMMARY:Earlier Surgical Intervention: Why This Might be the Best Option fo
 r You
DESCRIPTION:You're invited for a special World Glaucoma Week Facebook Live 
 Q&amp\;A with Dr Nathan Kerr on Monday 7th March at 7:00PM AEDT!\n \nDr Ke
 rr is the Principal Investigator and Clinical Lead for glaucoma surgical t
 rials in CERA’s Clinical Trials Research Centre. He is a pioneer of mini
 mally invasive glaucoma surgery\, having been the first surgeon in Austral
 ia to implant or be trained to perform several types of minimally invasive
  glaucoma surgery (MIGS) procedures in Australia.\n \nDr Kerr will discuss
  earlier surgical intervention in glaucoma and why this might be the best 
 option for you. He will also share the key benefits of MIGS treatment and 
 answer any questions you have!\n \nThis session will be hosted by Glaucoma
  Australia CEO Annie Gibbins. To attend\, simply head over to Glaucoma Aus
 tralia's Facebook page on Monday 7th March at 7PM AEDT and watch the video
  live.\n \nIf you have any questions you'd like to ask Dr Kerr about this 
 topic\, be sure to pop them in the comments below!\n \nSession Times by St
 ate:\n07:00pm AEDT (ACT\, NSW\, VIC\, TAS)\n6:30pm ACDT (SA)\n6:00pm AEST 
 (QLD)\n5.30pm ACST (NT)\n4:00pm AWST (WA)\n \n**More about Dr Kerr**\n \nD
 r Kerr’s primary research interest is the surgical management of glaucom
 a\, in particular to determine the safety\, clinical efficacy\, cost-effec
 tiveness\, and impact on quality of life of newer minimally invasive surgi
 cal techniques and implants compared to traditional therapies.\n \nUtilisi
 ng microscopic minimally invasive devices and new methods of medication de
 livery\, he is investigating new treatments that may one day replace the n
 eed for daily glaucoma eye drops.\n \nDr Kerr has been involved in several
  landmark clinical trials including the Primary Tube versus Trabeculectomy
  Study\, the Treatment of Advanced Glaucoma Study\, and the InnFocus Micro
 Shunt Study.
CATEGORIES:Public educational
LOCATION:Eye Surgery Associates\, Level 2\, 232 Victoria Parade\, Melbourne
 \, VIC\, 3002\, Australia
GEO:-37.809063;144.979642
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Level 2\, 232 Victoria Para
 de\, Melbourne\, VIC\, 3002\, Australia;X-APPLE-RADIUS=100;X-TITLE=Eye Sur
 gery Associates:geo:-37.809063,144.979642
END:VEVENT
BEGIN:VTIMEZONE
TZID:Australia/Sydney
X-LIC-LOCATION:Australia/Sydney
BEGIN:DAYLIGHT
DTSTART:20211003T030000
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR